论文部分内容阅读
医保支付价格如何定、谁来定,怎么调动医疗机构积极性成各地药价改革探索的着眼点。2017年,随着医保目录调整暂告一个段落,医保药品费用支付成为新的行业关注焦点。长期以来,中国医保部门给药品报销,是以医院市场零售价格为标准,按比例报销,医保甲类药品报销比例高于医保乙类。而医院市场零售价则挂钩省级招标,往往是在中标价基础上固定加成。
How to set the medical insurance to pay the price, who will be set, how to mobilize the enthusiasm of the medical institutions around the drug price reform exploration focus. In 2017, with the temporary promulgation of the Medicare catalog adjustment, the payment of Medicare drug fees has become a new industry focus. For a long time, China’s medical insurance department to reimburse drugs, based on the hospital retail price as the standard, in proportion to reimbursement, reimbursement of Medicare A class of drugs higher than the Medicare B class. The retail price of the hospital market is linked to the provincial bidding, often on the basis of a fixed price plus.